HCi Viocare’s smart sensor technology helps prevent pressure ulcers in bed-bound, wheel-chair patients

Glasgow-based bio-engineering group HCi Viocare - the company behind the Smart Insole invention that monitors diabetic feet – today announced that it is extending its push into healthcare by developing new adaptations of their innovative technology.

The company is adapting their sensor technology to be used in Smart Mattresses and Smart Wheelchair Cushions, designed to avoid debilitating pressure sores, and allowing patients and care givers more control over their lives.

The technology works by using a network of tiny electronic sensors to send data back to a smart device or mobile for real-time feedback or for later analysis.

The mattress and wheelchair cushion will use the electronic sensors to monitor potentially harmful pressure and shear forces among bedridden or wheelchair-using patients. Real-time feedback from the sensors will prompt the mattress or cushion to automatically adjust so that the patient is repositioned to help prevent ulcers forming.

HCi Viocare is in discussions with several partners who have shown significant interest in incorporating the new technology into their products and in producing the company’s new inventions.

Dr Christos Kapatos, HCi Viocare’s chief technical officer said:

We were delighted with the rapid and highly positive response to our Smart Insole invention – a reaction that has led us to expand our range of innovations.

We are now moving forward with new applications for our core technology, and continue to seek new partners who wish to commercialise this next generation of health products.

Our Smart Mattress and Wheelchair Cushion technology is developed to automatically respond to the pressure feedback from our sensors, adjusting the way the patient is positioned so that pressure ulcers don’t get a chance to form.

He also commented:

We are in discussions with relevant partners about the new products, validating our licensing model and encouraging us to find novel uses for our proprietary technology.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
EPAM Joins Sapio Sciences Partner Program